Translating human development to new therapies with pluripotent stem cells

利用多能干细胞将人类发育转化为新疗法

• 批准号: 368758
• 负责人: Keller Gordon M
• 金额: $ 331.51万
• 依托单位: University Health Network (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-09-01 至 2024-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=368758&lang=en
• 关键词: Cardiovascular Cells; Developmental Biology; Differentiation; Embryonic Stem Cells; Hematopoietic Cells; Hematopoietic Stem Cells; Hepatic Cells; Induced Pluripotent Stem Cells; Regenerative Medicine; Signaling Pathways

The goal of my Foundation application is to develop new stem cell-based therapies to treat blood, heart and liver diseases that affect millions of Canadians. Despite large investments by the pharmaceutical industry to bring new drugs to the market, heart

我的基金会申请的目标是开发新的基于干细胞的疗法，以治疗影响数百万加拿大人的血液，心脏和肝脏疾病。尽管制药行业投入大量资金将新药推向市场，